METASTATIC UTERINE CORPUS LEIOMYOSARCOMA

Clinical trials for METASTATIC UTERINE CORPUS LEIOMYOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC UTERINE CORPUS LEIOMYOSARCOMA trials appear

Sign up with your email to follow new studies for METASTATIC UTERINE CORPUS LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for Tough-to-Treat uterine cancer: trial tests promising drug duo

Disease control Ongoing

This study is for people with advanced uterine leiomyosarcoma, a type of cancer, that has continued to grow despite at least two prior chemotherapy treatments. It compares a new combination of two oral drugs, olaparib and temozolomide, against the current standard chemotherapy op…

Matched conditions: METASTATIC UTERINE CORPUS LEIOMYOSARCOMA

Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

METASTATIC UTERINE CORPUS LEIOMYOSARCOMA

Get alerted when new METASTATIC UTERINE CORPUS LEIOMYOSARCOMA trials appear

New hope for Tough-to-Treat uterine cancer: trial tests promising drug duo